1. Home
  2. WH vs HALO Comparison

WH vs HALO Comparison

Compare WH & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WH
  • HALO
  • Stock Information
  • Founded
  • WH 2017
  • HALO 1998
  • Country
  • WH United States
  • HALO United States
  • Employees
  • WH N/A
  • HALO N/A
  • Industry
  • WH Hotels/Resorts
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WH Consumer Discretionary
  • HALO Health Care
  • Exchange
  • WH Nasdaq
  • HALO Nasdaq
  • Market Cap
  • WH 8.5B
  • HALO 7.4B
  • IPO Year
  • WH N/A
  • HALO N/A
  • Fundamental
  • Price
  • WH $81.44
  • HALO $58.79
  • Analyst Decision
  • WH Strong Buy
  • HALO Buy
  • Analyst Count
  • WH 11
  • HALO 9
  • Target Price
  • WH $114.82
  • HALO $61.63
  • AVG Volume (30 Days)
  • WH 982.9K
  • HALO 1.8M
  • Earning Date
  • WH 04-30-2025
  • HALO 05-06-2025
  • Dividend Yield
  • WH 2.01%
  • HALO N/A
  • EPS Growth
  • WH 5.87
  • HALO 63.33
  • EPS
  • WH 3.61
  • HALO 3.43
  • Revenue
  • WH $1,404,000,000.00
  • HALO $1,015,324,000.00
  • Revenue This Year
  • WH $9.83
  • HALO $20.06
  • Revenue Next Year
  • WH $7.26
  • HALO $24.04
  • P/E Ratio
  • WH $22.56
  • HALO $17.14
  • Revenue Growth
  • WH 1.45
  • HALO 22.44
  • 52 Week Low
  • WH $67.67
  • HALO $37.73
  • 52 Week High
  • WH $113.07
  • HALO $66.00
  • Technical
  • Relative Strength Index (RSI)
  • WH 37.37
  • HALO 44.06
  • Support Level
  • WH $80.89
  • HALO $57.50
  • Resistance Level
  • WH $85.33
  • HALO $62.14
  • Average True Range (ATR)
  • WH 4.12
  • HALO 2.90
  • MACD
  • WH 0.08
  • HALO -0.40
  • Stochastic Oscillator
  • WH 30.13
  • HALO 36.41

About WH Wyndham Hotels & Resorts Inc.

As of Dec. 31, 2024, Wyndham Hotels & Resorts operates 903,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: